<!DOCTYPE html>
<!--[if IE 9]><html lang="en-US" class="no-js ie-9"> <![endif]-->
<!--[if gt IE 9]><!--> <html lang="en-US" class="no-js"><!--<![endif]-->
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<title>Topics | MoFo Life Sciences</title>
<meta name="description" itemprop="description" content>
<meta name="description" itemprop="keywords" content>
<link rel="canonical" href="http://lifesciences.mofo.com/topics/">
<link rel="stylesheet" id="validate-engine-css-css" href="css/blog-validationEngine.jquery.css" type="text/css" media="all">
<link rel="stylesheet" id="fontello-css" href="css/blog-embedded.css" type="text/css" media="all">
<link rel="stylesheet" id="mofo-fonts-css" href="css/blog-fonts.css" type="text/css" media="all">
<link rel="stylesheet" id="child-normalize-css" href="css/blog-normalize.css" type="text/css" media="all">
<link rel="stylesheet" id="child-foundation-css" href="css/blog-foundation.css" type="text/css" media="all">
<link rel="stylesheet" id="child-style-css" href="css/blog-style.css" type="text/css" media="all">
<link rel="stylesheet" id="child-jetpack-css" href="css/blog-jetpack.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-custom-style.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-print.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-simple-nav.css" type="text/css" media="all">
<link rel="shortcut icon" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png" type="image/icon">
<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="favicon.ico">
<link rel="icon" href="favicon.ico" type="image/icon">
<link rel="apple-touch-icon" type="image/png" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone -->
<link rel="apple-touch-icon" type="image/png" sizes="72x72" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPad -->
<link rel="apple-touch-icon" type="image/png" sizes="114x114" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone4 -->
<link rel="stylesheet" href="css/jquery-ui.css">


    <!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-T8Z9VLF');</script>
    <!-- End Google Tag Manager -->


<script defer src="js/all.js" crossorigin="anonymous"></script>

<!-- Jetpack Open Graph Tags -->
<meta property="og:type" content="website">
<meta property="og:title" content="MoFo Life Sciences">
<meta property="og:description" content="Because No One is Immune to the Law">
<meta property="og:url" content="https://lifesciences.mofo.com/">
<meta property="og:site_name" content="MoFo Life Sciences">
<meta property="og:image" content="https://s0.wp.com/i/blank.jpg">
<meta property="og:locale" content="en_US">





<style>
.svg-inline--fa {

    /*height: .8em;*/

    }
.svg-inline--fa {
    width: .475em;
}
 .sd-content a.nc-facebook-circled{
     color: #3b5998;
     font-size: 30px;
     }
     .sd-content a.nc-linkedin-circled{
     color: #0077b5;
     font-size: 30px;
     }
     .sd-content a.nc-twitter-circled{
     color: #00acee;
     font-size: 30px;
     }
     .sd-content a.nc-fa-envelope-square{
     color: #034193 ;
     font-size: 30px;
     }  
     .sd-content a.nc-fa-print{
     color: #000 ;
     font-size: 30px;
     }                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
     .sd-content a hover {
     }
     .sd-content i {
      margin: -4px;
     }
     #searchsubmit {
      font-size: 1em;
      border-radius: 3px;
      font-family: 'Oswald';
      text-transform: uppercase;
      letter-spacing: 2px;
      border-style: solid;
      border-width: 0;
      font-weight: 500;
    }
</style>

<meta name="google-site-verification" content="OD6S3RPM-cQOknAs1uXmBRvRJyh28rwkOoqdes47ZUE">
</head>
<body class="single single-post postid-${content.id} single-format-standard full-width custom-background-empty">
    <!-- Google Tag Manager (noscript) -->
    <noscript>
      <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-T8Z9VLF" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <!-- End Google Tag Manager (noscript) -->
    <script type="text/javascript"> 
<!-- 
var bb=new Image();var _ti=910;var _q="";var na=(navigator.appName=="Netscape");var ns=(navigator.appName.substring(0,9)=="Microsoft");var _qDate=new Date();var _r=(document.referrer.indexOf(getdomain(location))>-1?"":document.referrer);_q+="&5="+parseInt(_qDate.getTimezoneOffset());_q+="&35="+parseInt(_qDate.toString().indexOf("aylight")>-1?1:0);_q+="&6=903262841";_q+="&7=3262841";_q+="&8="+encodeURIComponent(document.location);_q+="&9="+encodeURIComponent(_r);_q+="&10="+encodeURIComponent(document.title);_q+="&11="+encodeURIComponent(navigator.userAgent);_q+="&12="+encodeURIComponent((na?navigator.language:navigator.userLanguage));_q+="&13="+((navigator.javaEnabled()?'1':'0'));if(document.cookie.indexOf("cc")==-1)document.cookie="cc=t;";_q+="&15="+((document.cookie.indexOf("cc")==-1)?"0":"1");_q+="&16="+encodeURIComponent((screen.width+'x'+screen.height));_q+="&17="+encodeURIComponent(((ns)?screen.colorDepth:screen.pixelDepth));_q+="&18="+encodeURIComponent(Math.random());_q+="&19="+_ti;bb.src="https://s.clickability.com/s?"+_q;
function setonclicks(a,b){var i=0;var retval=true;while(document.links[i]!=a){i++;}if(b.li[i])retval=b.li[i].oldonclick();bye(a);return retval;}
function newonld(){if(hasonload)oldonld();lnks=new Object();var sze=document.links.length;lnks.li=new Array(sze);for (var i=0; i<sze; i++){if(document.links[i].onclick){lnks.li[i]=document.links[i];lnks.li[i].oldonclick=document.links[i].onclick;}eval("document.links[i].onclick=function(){return setonclicks(this,lnks);}");}}function bye(a){if(a.href.toLowerCase().indexOf('http')!=0)return true;if(getdomain(location)==getdomain(a))return true;if(a.href.toLowerCase().indexOf('http')!=0)return true;var _qc="https://s.clickability.com/s?19=912";_qc+="&6=903262841";_qc+="&7=3262841";_qc+="&18="+encodeURIComponent(Math.random());_qc+="&100="+a.href;_qc+="&101="+encodeURIComponent(a.text);var cc=new Image();if(na){cc.src=_qc;pc(100);}else cc.src=_qc;return true;}function pc(a){d = new Date(); while (1){m =new Date(); df = m-d;if( df > a ) {break;}}}function getdomain(a){var i=a.host.indexOf(":");return (i>=0)?a.host.substring(0,i):a.host;}if(self['setupalready']){var dosetup = false;alert('There are two $imware.tracker calls on this page. Please alert Client Services');}else{var dosetup = true;var hasonload=false;}if(dosetup && ((window.screen)||((new Array()).toSource)||((new Array()).shift&&ns))&&(navigator.userAgent.indexOf('Mac')<0)){if(window.onload){oldonld=window.onload;hasonload=true;}window.onload=newonld;var setupalready = true;}//-->
</script><noscript>
<img alt="Clickability tracking pixel" width="1" height="1" src="https://s.clickability.com/s?19=990&amp;14=0&amp;6=903262841&amp;7=3262841&amp;25=0&amp;18=0.21093324047196904">
</noscript>

<div class="main-body-container" data-equalizer>    
<div class="nav_container">
	<a class="skip-link screen-reader-text" href="#content">Skip to content</a>  
        <div class="nav_wrap row ">
        	<div> <!-- add sticky here if needed -->
        	  <div>
                    <nav class="top-bar" data-topbar data-options="scrolltop:false;mobile_show_parent_link:false;">                  
                        <ul class="title-area">
	                        <li class="mofo-logo">
			                    <a href="https://www.mofo.com" title="Morrison & Foerster" target="_blank">
						<img src="https://media2.mofo.com/images/morrison-foerster-blog-logo.png" alt="logo">
			                    </a>
			                </li>
                            <li class="name">
                                <div class="header-title">
                                	<a href="index.html" title="MoFo Life Sciences" rel="home">
                                	                                	MoFo Life Sciences
                                	                                	</a>
                                </div>
                                                                <div class="header-subtitle">
                               		<span class="pms-7702c">Because No One is Immune to the Law</span>
                                </div>
                                                            </li>							
                            <!-- Remove the class "menu-icon" to get rid of menu icon. Take out "Menu" to just have icon alone -->
                                                    </ul>
</nav>
</div><!-- contain-to-grid sticky -->                
</div><!-- .row -->
</div>        
</div>
<!-- end .nav_container -->  


<div class="topnav" id="myTopnav">

<a href="index.html">Home</a>



<div class="divider"></div>
<div class="dropdown">

    <button class="dropbtn active">Topics 
     <i class="fa fa-caret-down"></i>
    </button>
    <div class="dropdown-content">

	
		 	<a href="topics_20.html">AI + Robotics</a>
		 	<a href="topics_5.html">Agtech</a>
		 	<a href="topics.html">Announcements</a>
		 	<a href="topics_2.html">Antitrust</a>
		 	<a href="topics_13.html">Asia</a>
		 	<a href="topics_9.html">Bioinformatics</a>
		 	<a href="topics_27.html">Biotech</a>
		 	<a href="topics_30.html">Blockchain</a>
		 	<a href="topics_6.html">CFIUS</a>
		 	<a href="topics_4.html">COVID-19</a>
		 	<a href="topics_16.html">Corporate + Venture Capital</a>
		 	<a href="topics_10.html">Data Analytics</a>
		 	<a href="topics_11.html">Digital Health</a>
		 	<a href="topics_23.html">Employment</a>
		 	<a href="topics_31.html">European Union</a>
		 	<a href="topics_18.html">FDA</a>
		 	<a href="topics_12.html">Financing</a>
		 	<a href="topics_29.html">Global</a>
		 	<a href="topics_21.html">Healthcare</a>
		 	<a href="topics_24.html">Intellectual Property</a>
		 	<a href="topics_3.html">Licensing + Commercial</a>
		 	<a href="topics_15.html">Litigation</a>
		 	<a href="topics_25.html">Medical Devices + Diagnostics</a>
		 	<a href="topics_17.html">Pharma</a>
		 	<a href="topics_19.html">Privacy + Data Security</a>
		 	<a href="topics_14.html">Product Liability + Class Action</a>
		 	<a href="topics_7.html">Rare Disease</a>
		 	<a href="topics_1.html">Regulatory</a>
		 	<a href="topics_26.html">Startup</a>
		 	<a href="topics_28.html">United Kingdom</a>
		 	<a href="topics_22.html">United States</a>
    </div>
  </div> 


<div class="divider"></div>
<a href="editors.html" class>Editors</a>


<div class="divider"></div>
<a href="about.html" class>About</a>


<div class="divider"></div>
<a href="javascript:void(0);" onclick="openSubscribeModal()" class>Subscribe</a>




<a href="javascript:void(0);" style="font-size:15px;" class="icon" onclick="myFunction()">&#9776;</a>
</div><div class="content_container">
    <section class="content_wrap row" role="document">
        <div id="content" class="medium-8 large-8 columns" role="main">
                        <header class="page-header">
                <h3>Topic Archives: <span>Litigation</span>
                </h3>
            </header>
                                                                                                
                                                            
                                                                
                                                                
                                                                
                                                            
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															            
            <article id="post-576396701" class="post-576396701 post type-post status-publish format-standard has-post-thumbnail hentry">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="stepping-stones-to-success-supporting-claims-in-the-life-sciences.html" title="Stepping Stones to Success: Supporting Claims in the Life Sciences">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/life-science-industries-thumb.jpg)"></div>
                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                <div class="rockwell pms-7702c">
                            <em>April 15, 2022</em>
                            - <a href="topics_5.html" rel="category tag">Agtech</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_15.html" rel="category tag">Litigation</a>, <a href="topics_22.html" rel="category tag">United States</a></div>
                            <h3>
                                <a href="stepping-stones-to-success-supporting-claims-in-the-life-sciences.html" title="Permalink to Stepping Stones to Success: Supporting Claims in the Life Sciences" rel="bookmark">
                                    Stepping Stones to Success: Supporting Claims in the Life Sciences</a>
                            </h3>
                            <div class="entry-meta">
                                <div class="blog-author-meta subheader">			
                                                                        

                                                                        By: Meghan McLean Poon
                                                                                                        </div>
                            </div>
                            <p>Owen Grayson Hosseinzadeh, Law Clerk in San Diego, contributed to the drafting of this post.

The standard for written description in the life sciences seems to have tightened lately, leading patent applicants to wonder what level of written support and working example data is necessary<span class="moretag">
                                    <a href="stepping-stones-to-success-supporting-claims-in-the-life-sciences.html"> &hellip;&rsaquo;</a>
                            </span>
                            </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                                                                        
                                                            
                                                                
                                                                
                                                                
                                                            
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										            
            <article id="post-576394221" class="post-576394221 post type-post status-publish format-standard has-post-thumbnail hentry">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="rulings-fda-guidance-may-help-food-cos-in-protein-suits.html" title="RULINGS, FDA GUIDANCE MAY HELP FOOD COS. IN PROTEIN SUITS">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/law360-logo-2021.png)"></div>
                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                <div class="rockwell pms-7702c">
                            <em>April 13, 2022</em>
                            - <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_15.html" rel="category tag">Litigation</a>, <a href="topics_14.html" rel="category tag">Product Liability + Class Action</a>, <a href="topics_1.html" rel="category tag">Regulatory</a></div>
                            <h3>
                                <a href="rulings-fda-guidance-may-help-food-cos-in-protein-suits.html" title="Permalink to RULINGS, FDA GUIDANCE MAY HELP FOOD COS. IN PROTEIN SUITS" rel="bookmark">
                                    RULINGS, FDA GUIDANCE MAY HELP FOOD COS. IN PROTEIN SUITS</a>
                            </h3>
                            <div class="entry-meta">
                                <div class="blog-author-meta subheader">			
                                                                        

                                                                        By: Claudia M. Vetesi, Nicole Victoria Ozeran, and Lena Gankin
                                                                                                        </div>
                            </div>
                            <p>Originally published by Law360, Claudia Vetesi, Nicole Ozeran, and Lena Gankin authored an article discussing a wave of protein-labeling lawsuits hitting food manufacturers, alleging that their products&rsquo; front-label protein content statements violate U.S. Food and Drug Administration (FDA) regulations, and mislead consumers by overstating<span class="moretag">
                                    <a href="rulings-fda-guidance-may-help-food-cos-in-protein-suits.html"> &hellip;&rsaquo;</a>
                            </span>
                            </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                                                                        
                                                            
                                                                
                                                                
                                                            
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															            
            <article id="post-576369051" class="post-576369051 post type-post status-publish format-standard has-post-thumbnail hentry">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="a-long-courtship-for-unity--as-europes-unitary-patent-system-is-going-live-soon-consultations-about-a-unitary-supplementary-protection-certificate-gain-momentum.html" title="A Long Courtship for Unity – As Europe’s Unitary Patent System Is Going Live Soon, Consultations About a Unitary Supplementary Protection Certificate Gain Momentum">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(images/06_30_federalcircuit_blog_sc1.jpg)"></div>
                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                <div class="rockwell pms-7702c">
                            <em>April 8, 2022</em>
                            - <a href="topics_31.html" rel="category tag">European Union</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_15.html" rel="category tag">Litigation</a></div>
                            <h3>
                                <a href="a-long-courtship-for-unity--as-europes-unitary-patent-system-is-going-live-soon-consultations-about-a-unitary-supplementary-protection-certificate-gain-momentum.html" title="Permalink to A Long Courtship for Unity – As Europe’s Unitary Patent System Is Going Live Soon, Consultations About a Unitary Supplementary Protection Certificate Gain Momentum" rel="bookmark">
                                    A Long Courtship for Unity – As Europe’s Unitary Patent System Is Going Live Soon, Consultations About a Unitary Supplementary Protection Certificate Gain Momentum</a>
                            </h3>
                            <div class="entry-meta">
                                <div class="blog-author-meta subheader">			
                                                                        

                                                                        By: Wolfgang Schönig and Jacqueline Madeleine Feigl
                                                                                                        </div>
                            </div>
                            <p>After a myriad of challenges, delays, and hurdles, the setting up of the pan-European patent court, the Unified Patent Court (UPC), is finally gaining traction. On January 19, 2022, the UPC came into existence as an international organization. This date marks the beginning of<span class="moretag">
                                    <a href="a-long-courtship-for-unity--as-europes-unitary-patent-system-is-going-live-soon-consultations-about-a-unitary-supplementary-protection-certificate-gain-momentum.html"> &hellip;&rsaquo;</a>
                            </span>
                            </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                                                                        
                                                            
                                                                
                                                                
                                                                
                                                                
                                                                
                                                            
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															            
            <article id="post-576291591" class="post-576291591 post type-post status-publish format-standard has-post-thumbnail hentry">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="possession-of-an-effective-dose.html" title="Possession of an " Effective" Dose">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(images/05-28-appellate-blog-image-16.jpg)"></div>
                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                <div class="rockwell pms-7702c">
                            <em>March 15, 2022</em>
                            - <a href="topics_27.html" rel="category tag">Biotech</a>, <a href="topics_21.html" rel="category tag">Healthcare</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_15.html" rel="category tag">Litigation</a>, <a href="topics_17.html" rel="category tag">Pharma</a>, <a href="topics_22.html" rel="category tag">United States</a></div>
                            <h3>
                                <a href="possession-of-an-effective-dose.html" title="Permalink to Possession of an " Effective" Dose" rel="bookmark">
                                    Possession of an "Effective" Dose</a>
                            </h3>
                            <div class="entry-meta">
                                <div class="blog-author-meta subheader">			
                                                                        

                                                                        By: Kelsey J Roberts Kingman and Bu Yin
                                                                                                        </div>
                            </div>
                            <p>Update: On March 16, 2022, the U.S. Court of Appeals for the Federal Circuit denied Biogen International&rsquo;s petition for panel rehearing and rehearing en banc, following a November split decision discussed below.

Judges Lourie, Moore, and Newman dissented on the denial of en banc rehearing.<span class="moretag">
                                    <a href="possession-of-an-effective-dose.html"> &hellip;&rsaquo;</a>
                            </span>
                            </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                                                                        
                                                            
                                                                
                                                                
                                                                
                                                                
                                                            
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									            
            <article id="post-576012951" class="post-576012951 post type-post status-publish format-standard has-post-thumbnail hentry">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="life-sciences-patent-trends-in-2022--doctrine-of-equivalents.html" title="Life Sciences Patent Trends in 2022 – Doctrine of Equivalents">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(images/mofolifesciences-biotech.jpg)"></div>
                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                <div class="rockwell pms-7702c">
                            <em>January 5, 2022</em>
                            - <a href="topics_27.html" rel="category tag">Biotech</a>, <a href="topics_21.html" rel="category tag">Healthcare</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_15.html" rel="category tag">Litigation</a>, <a href="topics_17.html" rel="category tag">Pharma</a></div>
                            <h3>
                                <a href="life-sciences-patent-trends-in-2022--doctrine-of-equivalents.html" title="Permalink to Life Sciences Patent Trends in 2022 – Doctrine of Equivalents" rel="bookmark">
                                    Life Sciences Patent Trends in 2022 – Doctrine of Equivalents</a>
                            </h3>
                            <div class="entry-meta">
                                <div class="blog-author-meta subheader">			
                                                                        

                                                                        By: Meghan McLean Poon
                                                                                                        </div>
                            </div>
                            <p>The Federal Circuit continues to tighten the standards for written description of functional claims, particularly in the biologics realm, which is putting patent applicants in the position of having to pursue narrow claims directed to specific sequences. At the same time, reliance on the<span class="moretag">
                                    <a href="life-sciences-patent-trends-in-2022--doctrine-of-equivalents.html"> &hellip;&rsaquo;</a>
                            </span>
                            </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                                                                        
                                                            
                                                                
                                                                
                                                                
                                                            
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		            
            <article id="post-575961621" class="post-575961621 post type-post status-publish format-standard has-post-thumbnail hentry">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="3-key-takeaways-from-fdlis-fda-center-compliance-directors-presentations-and-qa-session.html" title="3 Key Takeaways from FDLI’s FDA Center Compliance Directors: Presentations and Q&A Session">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-litigation.jpg)"></div>
                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                <div class="rockwell pms-7702c">
                            <em>December 22, 2021</em>
                            - <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_21.html" rel="category tag">Healthcare</a>, <a href="topics_15.html" rel="category tag">Litigation</a>, <a href="topics_25.html" rel="category tag">Medical Devices + Diagnostics</a></div>
                            <h3>
                                <a href="3-key-takeaways-from-fdlis-fda-center-compliance-directors-presentations-and-qa-session.html" title="Permalink to 3 Key Takeaways from FDLI’s FDA Center Compliance Directors: Presentations and Q&A Session" rel="bookmark">
                                    3 Key Takeaways from FDLI’s FDA Center Compliance Directors: Presentations and Q&A Session</a>
                            </h3>
                            <div class="entry-meta">
                                <div class="blog-author-meta subheader">			
                                                                        

                                                                        By: Rachel Park
                                                                                                        </div>
                            </div>
                            <p>FDLI hosted a virtual Enforcement, Litigation, and Compliance Conference December 9&ndash;10, 2021.  The session titled Compliance Central with FDA Center Compliance Directors: Presentations and Q&amp;A addressed FDA&rsquo;s top compliance issues, enforcement priorities, and goals for 2022.  The session included presentations from Ann<span class="moretag">
                                    <a href="3-key-takeaways-from-fdlis-fda-center-compliance-directors-presentations-and-qa-session.html"> &hellip;&rsaquo;</a>
                            </span>
                            </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                                                                        
                                                            
                                                                
                                                                
                                                                
                                                                
                                                            
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																									            
            <article id="post-575489261" class="post-575489261 post type-post status-publish format-standard has-post-thumbnail hentry">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="skinny-labels-back-in-focus-after-HHS-report-on-addressing-drug-prices.html" title="Skinny Labels Back in Focus after HHS Report on Addressing Drug Prices ">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-pharma.jpg)"></div>
                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                <div class="rockwell pms-7702c">
                            <em>October 8, 2021</em>
                            - <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_15.html" rel="category tag">Litigation</a>, <a href="topics_17.html" rel="category tag">Pharma</a>, <a href="topics_22.html" rel="category tag">United States</a></div>
                            <h3>
                                <a href="skinny-labels-back-in-focus-after-HHS-report-on-addressing-drug-prices.html" title="Permalink to Skinny Labels Back in Focus after HHS Report on Addressing Drug Prices " rel="bookmark">
                                    Skinny Labels Back in Focus after HHS Report on Addressing Drug Prices </a>
                            </h3>
                            <div class="entry-meta">
                                <div class="blog-author-meta subheader">			
                                                                        

                                                                        By: Fitz B. Collings
                                                                                                        </div>
                            </div>
                            <p>Skinny labels are back in focus at the White House. On September 9, 2021, the U.S. Department of Health and Human Services submitted its much-anticipated report to the White House Competition Counsel regarding a &ldquo;Comprehensive Plan for Addressing High Drug Prices.&rdquo; The HHS Report&mdash;issued<span class="moretag">
                                    <a href="skinny-labels-back-in-focus-after-HHS-report-on-addressing-drug-prices.html"> &hellip;&rsaquo;</a>
                            </span>
                            </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                                                                        
                                                            
                                                                
                                                            
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														            
            <article id="post-574501051" class="post-574501051 post type-post status-publish format-standard has-post-thumbnail hentry">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="the-european-commissions-take-on-novel-genomic-techniques-ngts-in-light-of-cjeus-ruling-in-case-c-52816.html" title="The European Commission’s Take on Novel Genomic Techniques (NGTs) in Light of CJEU’s Ruling in Case C-528/16">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-eu.jpg)"></div>
                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                <div class="rockwell pms-7702c">
                            <em>May 26, 2021</em>
                            - <a href="topics_31.html" rel="category tag">European Union</a>, <a href="topics_15.html" rel="category tag">Litigation</a></div>
                            <h3>
                                <a href="the-european-commissions-take-on-novel-genomic-techniques-ngts-in-light-of-cjeus-ruling-in-case-c-52816.html" title="Permalink to The European Commission’s Take on Novel Genomic Techniques (NGTs) in Light of CJEU’s Ruling in Case C-528/16" rel="bookmark">
                                    The European Commission’s Take on Novel Genomic Techniques (NGTs) in Light of CJEU’s Ruling in Case C-528/16</a>
                            </h3>
                            <div class="entry-meta">
                                <div class="blog-author-meta subheader">			
                                                                        

                                                                        By: Wolfgang Schönig
                                                                                                        </div>
                            </div>
                            <p>Summary


     - The decision of the Court of      Justice of the European Union (CJEU) in case C-528/16 essentially banning      novel genomic techniques (NGTs), in particular novel mutagenesis<span class="moretag">
                                    <a href="the-european-commissions-take-on-novel-genomic-techniques-ngts-in-light-of-cjeus-ruling-in-case-c-52816.html"> &hellip;&rsaquo;</a>
                            </span>
                            </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                                                                        
                                                            
                                                                
                                                            
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										            
            <article id="post-574342351" class="post-574342351 post type-post status-publish format-standard has-post-thumbnail hentry">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="ninth_circuit_weighs_in_on_fraud_on_the_fda_theory_marketing_devices_for_off_label_use_kickbacks.html" title="Ninth Circuit Weighs in on Fraud-on-the-FDA Theory, Marketing Devices for Off-Label Use, and Kickbacks">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-medical-devices.jpg)"></div>
                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                <div class="rockwell pms-7702c">
                            <em>May 4, 2021</em>
                            - <a href="topics_18.html" rel="category tag">FDA</a>, <a href="topics_15.html" rel="category tag">Litigation</a></div>
                            <h3>
                                <a href="ninth_circuit_weighs_in_on_fraud_on_the_fda_theory_marketing_devices_for_off_label_use_kickbacks.html" title="Permalink to Ninth Circuit Weighs in on Fraud-on-the-FDA Theory, Marketing Devices for Off-Label Use, and Kickbacks" rel="bookmark">
                                    Ninth Circuit Weighs in on Fraud-on-the-FDA Theory, Marketing Devices for Off-Label Use, and Kickbacks</a>
                            </h3>
                            <div class="entry-meta">
                                <div class="blog-author-meta subheader">			
                                                                        

                                                                                                        </div>
                            </div>
                            <p>The Ninth Circuit recently weighed in on the appeal of a False Claims Act lawsuit from a relator against Medtronic. In this case, the relator alleges that Medtronic, Inc.:

(1)  Engaged in &ldquo;fraud-on-the-FDA&rdquo; when obtaining clearance for several devices used in spinal fusion surgeries;
(2)<span class="moretag">
                                    <a href="ninth_circuit_weighs_in_on_fraud_on_the_fda_theory_marketing_devices_for_off_label_use_kickbacks.html"> &hellip;&rsaquo;</a>
                            </span>
                            </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                                                                        
                                                            
                                                                
                                                                
                                                                
                                                                
                                                            
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																												            
            <article id="post-574235531" class="post-574235531 post type-post status-publish format-standard has-post-thumbnail hentry">
                <div class="post-box">
                    <div class="row">
                                                <div class="medium-3 columns">
                            <a href="pay-for-delay-has-tough-antitrust-time-at-EU-top-court.html" title="Pay-for-Delay has a tough (antitrust) time at EU Top Court">
                                                         <div class="attachment-thumbnail size-thumbnail wp-post-image thumb" style="background-image:url(https://media2.mofo.com/images/mofolifesciences-eu.jpg)"></div>
                                                        </a>
                        </div>
                        <div class="medium-9 columns">
                                                <div class="rockwell pms-7702c">
                            <em>April 19, 2021</em>
                            - <a href="topics_2.html" rel="category tag">Antitrust</a>, <a href="topics_31.html" rel="category tag">European Union</a>, <a href="topics_24.html" rel="category tag">Intellectual Property</a>, <a href="topics_15.html" rel="category tag">Litigation</a>, <a href="topics_17.html" rel="category tag">Pharma</a></div>
                            <h3>
                                <a href="pay-for-delay-has-tough-antitrust-time-at-EU-top-court.html" title="Permalink to Pay-for-Delay has a tough (antitrust) time at EU Top Court" rel="bookmark">
                                    Pay-for-Delay has a tough (antitrust) time at EU Top Court</a>
                            </h3>
                            <div class="entry-meta">
                                <div class="blog-author-meta subheader">			
                                                                        

                                                                        By: Jens Hackl and Andreas Grünwald
                                                                                                        </div>
                            </div>
                            <p>In recent years, there have been various antitrust investigations in the pharmaceutical sector resulting in decisions of the European Commission (EC) and the European Courts.[1] In two recent rulings &ndash; &ldquo;Lundbeck&rdquo;[2] and &ldquo;Paroxetine&rdquo;[3] &ndash; the European Court of Justice (ECJ) dealt with settlement agreements<span class="moretag">
                                    <a href="pay-for-delay-has-tough-antitrust-time-at-EU-top-court.html"> &hellip;&rsaquo;</a>
                            </span>
                            </p>
                            </div>
                        </div>
                    </div>
</article>
<!-- #post -->
                        <nav id="nav-below" class="navigation" role="navigation">
                <h3 class="assistive-text">Post Navigation</h3>
                                                    <div class="nav-previous alignleft">
                        <a href="topics_38.html">
                            <span class="meta-nav">«</span>
                            Older Posts</a>
                    </div>
                                            <a href="topics_38.html">&lt;&lt;</a>
                    
                                                                </nav>
<!-- #nav-below .navigation --> 
    </div>
    <!-- #content -->
    <div id="secondary" class="medium-4 large-4 columns widget-area data-equalizer-watch" role="complementary">
                

<aside id="black-studio-tinymce-3" class="widget widget_black_studio_tinymce">
    <div class="textwidget">
        <div class="gray-sidebar">
            <h5>Stay Connected </h5>
                                        <a title="Connect via LinkedIn" class="nc-linkedin-circled" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via Twitter" class="nc-twitter-circled" href="https://twitter.com/MoFoLLP" target="_blank">
                        <i class="icon-twitter-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via RSS" class="nc-rss" href="rss" target="_blank">
                        <i class="icon-rss footer-icons black85"></i>
                    </a>
                            </div>
    </div>
</aside>
<aside id="search-2" class="widget widget_search">
    <form role="search" method="get" id="searchform" action="/search/">
        <div class="row collapse">
            <div class="medium-12 large-12 columns">
                <input type="text" value name="s" id="s">
                    <div class="search-icon">
                        <i class="icon-search footer-icons pms-7702c"></i>
                    </div>
                    <input type="submit" id="searchsubmit" value="Search" class="search-btn">
                    </div>
</div>
</form>
</aside>
<aside id="categories-2" class="widget widget_categories">
    <h6 class="widget-title">Topics</h6>
            <label class="screen-reader-text" for="cat">Topics</label>
            <select name="cat" id="cat" class="postform">
                <option value="-1">Topics</option>
                                                                                                                                                <option class="level-0" value="1457511">AI + Robotics</option>
                                                                                                <option class="level-0" value="1457521">Agtech</option>
                                                                                                <option class="level-0" value="1457691">Announcements</option>
                                                                                                <option class="level-0" value="1462201">Antitrust</option>
                                                                                                <option class="level-0" value="1457531">Asia</option>
                                                                                                <option class="level-0" value="1468521">Bioinformatics</option>
                                                                                                <option class="level-0" value="1456751">Biotech</option>
                                                                                                <option class="level-0" value="1458171">Blockchain</option>
                                                                                                <option class="level-0" value="1458511">CFIUS</option>
                                                                                                <option class="level-0" value="1462211">COVID-19</option>
                                                                                                <option class="level-0" value="1457541">Corporate + Venture Capital</option>
                                                                                                <option class="level-0" value="1458861">Data Analytics</option>
                                                                                                <option class="level-0" value="1465651">Digital Health</option>
                                                                                                <option class="level-0" value="1458521">Employment</option>
                                                                                                <option class="level-0" value="1457551">European Union</option>
                                                                                                <option class="level-0" value="1459381">FDA</option>
                                                                                                <option class="level-0" value="1457561">Financing</option>
                                                                                                <option class="level-0" value="1459511">Global</option>
                                                                                                <option class="level-0" value="1459951">Healthcare</option>
                                                                                                <option class="level-0" value="1457581">Intellectual Property</option>
                                                                                                <option class="level-0" value="1457591">Licensing + Commercial</option>
                                                                                                <option class="level-0" value="1457601">Litigation</option>
                                                                                                <option class="level-0" value="1459061">Medical Devices + Diagnostics</option>
                                                                                                <option class="level-0" value="1457631">Pharma</option>
                                                                                                <option class="level-0" value="1457641">Privacy + Data Security</option>
                                                                                                <option class="level-0" value="1457651">Product Liability + Class Action</option>
                                                                                                <option class="level-0" value="1465361">Rare Disease</option>
                                                                                                <option class="level-0" value="1459071">Regulatory</option>
                                                                                                <option class="level-0" value="1459521">Startup</option>
                                                                                                <option class="level-0" value="1462611">United Kingdom</option>
                                                                                                <option class="level-0" value="1457671">United States</option>
                                                            </select>
            <script type="text/javascript">
                /* <![CDATA[ */
                (function() {
                var dropdown = document.getElementById( "cat" );
                function onCatChange() {
                if ( dropdown.options[ dropdown.selectedIndex ].value > 0 ) {
                location.href = "/topics/?c=" + dropdown.options[ dropdown.selectedIndex ].value;
                }
                }
                dropdown.onchange = onCatChange;
                })();
                /* ]]> */
            </script>
</aside>
<aside class="widget widget_recent_entries">
    <h6 class="widget-title">Recent Posts</h6>
            <ul>
                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force-part-3-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE (PART 3 OF 3)</a>
                    </li>
                                                                    <li>
                        <a href="fda-will-once-again-accept-pre-submissions-for-all-in-vitro-diagnostic-tests.html">FDA Will Once Again Accept Pre-Submissions for All In Vitro Diagnostic Tests</a>
                    </li>
                                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force--part-2-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE  (PART 2 OF 3) </a>
                    </li>
                                                                    <li>
                        <a href="eu-in-vitro-diagnostic-regulation-entered-into-force--part-1-of-3.html">EU: IN VITRO DIAGNOSTIC REGULATION ENTERED INTO FORCE  (PART 1 OF 3) </a>
                    </li>
                                                                    <li>
                        <a href="senators-call-for-report-on-state-of-psychedelic-research.html">Senators Call for Report on State of Psychedelic Research</a>
                    </li>
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </ul>
</aside>
<aside id="black-studio-tinymce-6" class="widget widget_black_studio_tinymce">
     <style>

address {
  font-style: normal;
  margin-bottom: 14px;
  margin-left: 10px;
}

address .contact  {
  display: block;
  
}

address .email a:hover {
  color: #0078a0;
}

.location, .attorney, .email {
  display: block;

}

address .email a {
color: #5e5f61;
}

.location {
  font-weight: 900;
  font-family: 'Oswald', sans-serif;
  text-transform: uppercase;
}

.contact-title {
  font-family: 'Oswald', sans-serif;
  font-size: .825em;
  background-color: #eeeeee;
  padding: .8em;
  letter-spacing: 2px;
  text-transform: uppercase;
  margin-bottom: 10px;
  display: block;
  font-weight: 900;
}

</style>




</aside>
    </div>
    <!-- #secondary -->
</section>
<!-- end .content-wrap -->
                </div>
                <!-- end .content_container -->
 <div style="display:none;" id="dialog-message" title="Email Disclaimer">
	<p>Unsolicited e-mails and information sent to Morrison &amp; Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison &amp; Foerster. If you are not already a client of Morrison &amp; Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.</p>
</div>
<div class="footer_container">
    <footer class="footer_wrap row" role="contentinfo">
        <div id="footer" class="row" role="contentinfo">
            <div class="columns medium-12 footer-nav-wrapper">
                <div class="footer-nav">
                    <ul>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-terms-of-use">
                            <a target="_blank" href="https://www.mofo.com/about/terms-notices.html">Terms of Use</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-cookies">
                            <a target="_blank" href="https://www.mofo.com/about/cookies.html">Cookies</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-privacy-policy">
                            <a target="_blank" href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-disclaimer">
                            <a target="_blank" href="https://www.mofo.com/special-content/blog-disclaimer/">Disclaimer</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-attorney-advertising">
                            <a target="_blank" href="https://www.mofo.com/about/attorney-advertising.html">Attorney Advertising</a>
                        </li>
                        </ul></div>
                </div>
                <div class="columns medium-12 text-center">
                    <p class="copyright">&copy;1996-2022 Morrison &amp; Foerster LLP. <span class="show-for-small"><br></span>All Rights Reserved.</p>
                </div>
                <div class="medium-2 medium-centered columns">
                                                            <a title="Connect via LinkedIn" class="nc-linkedin" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via Twitter" class="nc-twitter" href="https://twitter.com/MoFoLLP" target="_blank">
                        <i class="icon-twitter-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via RSS" class="nc-rss" href="rss" target="_blank">
                        <i class="icon-rss footer-icons pms-7702c"></i>
                    </a>
                                    </div>
                                            </div>
</footer>
<!-- .row -->
</div>
<!-- end #footer_container -->
<div id="backtotop" class="hvr-fade">
    <span class="genericon genericon-collapse"></span>
</div>
<!-- #backtotop -->

</div>
     <div class="textwidget">
        <div id="subscribe-modal" class="reveal-modal" data-reveal aria-labelledby="subscribe-modal" aria-hidden="true" role="dialog">
            <aside class="widget widget_black_studio_tinymce">
                <div class="textwidget newsletter_subscribe">
                    <div>
                        <h5>Subscribe</h5>
                                <p>Never miss a post from MoFo Life Sciences. Enter your email below to stay up-to-date.</p>
                    </div>
                </div>
                            </aside>
            <p>
                <div class="resultLabel"></div>
                <div class="widget_wysija_cont shortcode_wysija newsletter_subscribe">
                                   <iframe src="https://www2.mofo.com/l/323401/2020-09-03/621wk" width="100%" height="450" type="text/html" frameborder="0" allowTransparency="true" style="border: 0"></iframe>
                                                </div>
                    <a class="close-reveal-modal" onClick="closeSubscriptionModal()" aria-label="Close"></a>
</p></div>
</div>



<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
  ga('create', 'UA-12456654-15', 'auto');   ga('send', 'pageview');
</script>

<script type="text/javascript"> 
/*<![CDATA[*/ 
(function() { 
var sz = document.createElement('script'); sz.type = 'text/javascript'; sz.async = true; 
sz.src = '//siteimproveanalytics.com/js/siteanalyze_59840.js'; 
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(sz, s); 
})(); 
/*]]>*/ 
</script>




<script>
  function myFunction() {
    var x = document.getElementById("myTopnav");
    if (x.className === "topnav") {
      x.className += " responsive";
    } else {
      x.className = "topnav";
    }
  }
  </script>
  
  
  <script>
  

function openSubscribeModal() {
console.log('openSubscribeModal')
  var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'visible';
  m.style.display = 'block';
  }
  
  function closeSubscriptionModal() {
    var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'hidden';
  m.style.display = 'none';
  }

  </script>
  

</body>
</html>
